Concepedia

Deborah Toppmeyer

DT

Statistics

Publications

60

Citations

9.5K

H-Index

32

Active since

1992

Affiliations

Rutgers, The State University of New Jersey(Current)

Rutgers Cancer Institute

Dana-Farber Cancer Institute

Johnson University

Memorial Sloan Kettering Cancer Center

Deborah Toppmeyer is an author at Rutgers, The State University of New Jersey specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1992–2023

60

Publications

60

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2018 · 2.4K citations · Full text

, , +17

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

, , +16

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

Bruce G. Haffty, Qifeng Yang, Thomas Kearney et al. · Journal of Clinical Oncology · 2006 · 1.1K citations · Full text

, , +16

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

Sylvia Adams, Sherene Loi, Deborah Toppmeyer et al. · Annals of Oncology · 2018 · 631 citations

, , +17

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin et al. · New England Journal of Medicine · 2019 · 555 citations · Full text

, , +16

1–5 of 60